stars 1 stars 2 stars 3

ANEUROTECH is developing its late stage Phase III drug ANT01 in Partial Responsive Depression (PRD). ANT01 is an once daily, orally-administered small molecule to attack Subjective Cognitive Decline and Potentiate Initial Antidepressant Therapies.

View Top Employees from ANeuroTech

ANeuroTech Questions

The ANeuroTech annual revenue was $211000 in 2024.

2 people are employed at ANeuroTech.

ANeuroTech is based in Alken, Flanders.

The NAICS codes for ANeuroTech are [3254, 32, 325, 32541].

The SIC codes for ANeuroTech are [283, 28].

Top ANeuroTech Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users